A Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients
Launched by MEDICAL UNIVERSITY OF VIENNA · May 13, 2014
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new, less invasive surgical method to help patients who have a specific condition called maxillary sinus atrophy, which means they have a reduced amount of bone in the upper jaw. The goal of the study is to find out if this modified technique can safely create enough bone height (at least 10mm) in the sinus area to support dental implants after a healing period of 3 to 5 months. The researchers believe that this new approach will also help make the procedure less stressful for patients.
To be eligible for the trial, participants must be between the ages of 18 to 75 and have a bone height of 3 to 6mm and a width of more than 4mm in the jaw area. However, individuals who have untreated gum disease, smoke more than five cigarettes a day, or have sinus infections will not be able to join. If you participate, you can expect to undergo this modified surgery and then have follow-up visits to monitor your healing progress.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • residual bone height of 3-6mm
- • residual bone width of \>4mm
- Exclusion Criteria:
- • not treated periodontal disease
- • smoker (\>5cig/day)
- • acute or chronic sinusitis
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials